Use of capsaicin in the treatment of radicular pain in spinal cord injury

Journal of Spinal Cord Medicine

Volumn 23, Issue 4, 2000, Pages 238-243

  Sandford, Paul R ^a,b   Benes, Paula S ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b FROEDTERT MEMORIAL LUTHERAN HOSPITAL   (United States)

Author keywords

Capsaicin; Pain; Spinal cord injury

Indexed keywords

EID: 0003202727     PISSN: 10790268     EISSN: None     Source Type: Journal    
DOI: 10.1080/10790268.2000.11753532     Document Type: Article

References (31)

1. Ragnarsson KT. Management of pain in persons with spinal cord injury. J Spinal Cord Inj Med. 1997;20(2):186-199.
2. Britell CW, Mariano AJ. Chronic pain in spinal cord injury. In: Phys Med Rehabil: State of the Art Rev. 1991;5:71-82.
3. Nepomuceno C, Fine PR, Richards JS, et al. Pain in patients with spinal cord injury. Arch Phys Med Rehabil. 1979;60:605-609.
4. Rintala DH, Loubser PF, Castro J, Hart K, Fuhrer MJ. Chronic pain in a community-based sample of men with spinal cord injury: Prevalence, severity, and relationship with impairment, disability, handicap, and subjective well-being. Arch Phys Med Rehabil. 1998;79:604-614.
5. Loubser PG, Donovan WH. Diagnostic spinal anaesthesia in chronic spinal cord injury pain. Paraplegia. 1991;29(1):25-36.
6. Watson CPN, Evans RJ, Watt VR. Post-herpetic neuralgia and topical capsaicin. Pain. 1988;33:333-340.
7. Bernstein JE, Korman NJ, Bickers DR, Dahl MV, Millikan LE. Topical capsaicin treatment of chronic postherpetic neuralgia. J Am Acad Derm. 1989;21:265-270.
8. Tandan R, Lewis GA, Krusinski PB, Badger GB, Fries, TJ. Topical capsaicin in painful diabetic neuropathy: Controlled study with long-term follow-up. Diabetes Care. 1992;15:8-14.
9. Tandan R, Lewis GA, Badger GB, Fries TJ. Topical capsaicin in painful diabetic neuropathy: Effect on sensory function. Diabetes Care. 1992;15:15-18.
10. The Capsaicin Study Group. Treatment of painful diabetic neuropathy with topical capsaicin. A multicenter, double-blind, vehicle-controlled study. Arch Intern Med. 1991;151:2225-2229.
11. Watson CPN, Evans RJ. The postmastectomy pain syndrome and topical capsaicin: A randomized trial. Pain. 1992;51(3):375-379.
12. Cannon DT, Wu Y. Topical capsaicin as an adjuvant analgesic for the treatment of traumatic amputee neurogenic residual limb pain. Arch Phys Med Rehabil. 1998;79:591-593.
13. Donovan WH, Dimitrijevic MR, Dahm L, Dimitrijevic, M. Neurophysiological approaches to chronic pain following spinal cord injury. Paraplegia. 1982;20(3):135-146.
14. Frisbie JH, Aguilera EJ. Chronic pain after SCI: An expedient diagnostic approach. Paraplegia. 1990;28(7):460-465.
15. Farkash AE, Portenoy RK. The pharmacological management of chronic pain in the paraplegic patient. J Am Paraplegia Soc. 1986;9(3-4):41-50.
16. Tunks E. Pain in spinal cord injured patients. In: Bloch RF, Basbaum M, eds. Management of Spinal Cord Injuries. Baltimore, Md: Williams and Wilkins; 1986: 180-211.
17. Brusky J. Central and post-spinal cord-injury pain. In: Abram SE, ed. The Pain Clinic Manual. Philadelphia, Penn: JB Lippincott Co.; 1990: 217-224.
18. Gibson JC, White LE. Denervation hyperpathia: A convulsive syndrome of the spinal cord responsive to carbamazepine therapy. J Neurosurg. 1971;35:287-290.
19. Maury M. About pain and its treatment in paraplegics, [proceedings] Paraplegia. 1978;15(4):349-352.
20. Davidoff G, Guarracini M, Roth E, Sliwa J, Yarkony G. Trazodone hydrochloride in the treatment of dysesthetic pain in traumatic myelopathy: A randomized, double-blind, placebo-controlled study. Pain. 1987;29(2):151-161.
21. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: A randomized controlled trial. JAMA. 1998;280:1837-1842.
22. Backonja M, Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial. JAMA 1998;280:1831-1836.
23. Sandford PR, Lindblom LL, Haddox JD. Amitriptyline and carbamazepine in the treatment of dysesthetic pain in spinal cord injury. Arch Phys Med Rehabil. 1992;73:300-301.
24. Heilporn A. Two therapeutic experiments on stubborn pain in spinal cord lesions: Coupling melitraden-fluplenthixol and the transcutaneous nerve stimulation, [proceedings] Paraplegia. 1978;15:368-372.
25. Buck SH, Burks TF. The neuropharmacology of capsaicin: Review of some recent observations. Pharm Rev. 1986;38(3):179-226.
26. Jancso N, Jancso-Gabor A, Szolcs'anyi J. Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. Br J Pharmacol. 1967;31:138-151.
27. Lynn B. Capsaicin: Actions of nociceptive C-fibres and therapeutic potential. Pain. 1990;41(1):61-69.
28. Simone DA, Ochoa J. Early and late effects of prolonged topical capsaicin on cutaneous sensibility and neurogenic vasodilatation in humans. Pain. 1991;47(3):285-294.
29. Bernstein JE, Bickers DR, Dahl MV, Roshai JY. Treatment of chronic postherpetic neuralgia with topical capsaicin. J Am Acad Derm. 1987;17:93-96.
30. Basbaum AI, Gautron M, Jazat F, Mayes M, Guilbaud G. The spectrum of fiber loss in the model of neuropathic pain in the rat: An electron microscopic study. Pain. 1991;47:359-367.
31. Walker FO, Lewis SF. Somesthetic and electrophysiologic effects of topical capsaicin in man. Reg Anesth. 1990;15:61-66.